Curcumin Nanoparticles Shield Liver and Kidneys From Radiation
A rat study found curcumin nanoparticles reduced radiation-induced damage to the liver and kidneys.
Updated on Nov. 5, 2026 in Nutrition
Researchers reported that curcumin nanoparticles reduced radiation-induced liver and kidney injury in rats, according to a study published as an early-access, accepted peer-reviewed article on November 5, 2026. Treated animals showed preserved tissue structure and less inflammation than rats exposed to radiation alone.
Why it matters
Radiation exposure from cancer treatment can damage healthy organs, and the findings suggest curcumin nanoparticles could one day help limit that toxicity. The results come from animal research, so their relevance to human patients remains to be established.
The study used 30 male Wistar rats divided into six groups, with a single 6 Gy radiation dose given to the radiation-only group. Curcumin nanoparticles were tested at 2 mg/kg and 4 mg/kg, and the two doses showed no apparent difference in effect.
The players
Hamadan University of Medical Sciences
Hamadan University of Medical Sciences is a public medical university in Hamadan, Iran, that supported the research.
The details
Researchers gave curcumin nanoparticles to rats before radiation exposure, then collected liver and kidney tissues for histopathological examination. Rats that received radiation alone showed hepatocyte degeneration, inflammation, and tubular necrosis, while treated groups showed reduced pathological changes and preserved tissue architecture.
Timeline
November 5, 2026: Article published early as accepted peer-reviewed research.
Health Landscape
Curcumin has been studied for its antioxidant and anti-inflammatory properties for years, and this work extends that research by testing a nanoparticle formulation against radiation-specific organ injury. The shift from whole-compound to nanoparticle delivery reflects broader efforts to improve how poorly absorbed natural compounds reach target tissues.
For people undergoing radiotherapy, this research is at the animal-study stage and does not yet change any treatment options. Any future use of curcumin as a supplement during cancer care would need clinical trials and medical supervision before it could be recommended.
The takeaway
Animal results like these are an early step, and readers should not start taking curcumin supplements in place of medical care. Anyone with questions about radiation side effects should discuss them with their oncology team.
Further reading
For related context on dietary compounds and health, explore our Nutrition coverage.
Source note: This article includes information reported by Nature.
